Eye Tracking Impact on Quality-of-Life of ALS Patients

Chronic neurological disorders in their advanced phase are characterized by a progressive loss of mobility (use of upper and lower limbs), speech and social life. Some of these pathologies, such as amyotrophic lateral sclerosis and multiple sclerosis, are paradigmatic of these deficits. High technology communication instruments, such as eye tracking, can be an extremely important possibility to reintroduce these patients in their family and social life, in particular when they suffer severe disability. This paper reports and describes the results of an ongoing experimentation about Eye Tracking impact on the quality of life of amyotrophic lateral sclerosis patients. The aim of the experimentation is to evaluate if and when eye tracking technologies have a positive impact on patients' live

Plasma antibodies against heat shock protein 70 correlate with the incidence and severity of asthma in a Chinese population

BACKGROUND: The heat shock proteins (Hsps) are induced by stresses such as allergic factors and inflammatory responses in bronchi epithelial cells and therefore may be detectable in patients with asthma. However, the etiologic link between anti-Hsps and asthma (its severity and related inflammatory responses such as interleukin-4 and immunoglobulin E) has not been established. We determined whether antibodies against Hsp60 and Hsp70 were present in patients with asthma and evaluated their associations with risk and severity of asthma. METHODS: We determined the levels of anti-Hsp60 and anti-Hsp70 by immunoblot and their associations with risk and symptom severity of asthma in 95 patients with asthma and 99 matched non-symptomatic controls using multivariate logistic regression analysis. RESULTS: Compared to the controls, asthma patients were more likely to have detectable anti-Hsp60 (17.2% vs 5.1%) and anti-Hsp70 (33.7% vs 8.1%) (p ≤ 0.001). In particular, the presence of anti-Hsp70 was associated with a greater than 2 fold risk for asthma (adjusted OR = 2.21; 95% CI = 1.35~3.59). Furthermore, both anti-Hsp60 and anti-Hsp70 levels were positively correlated with symptom severity (p < 0.05) as well as interleukin-4 and immunoglobulin E (p < 0.05). Individuals with antibodies against anti-Hsp60 and anti-Hsp70 were more likely to have a family history of asthma (p < 0.001) and higher plasma concentrations of total immunoglobulin E (p = 0.001) and interleukin-4 (p < 0.05) than those without antibodies. CONCLUSIONS: These data suggest that anti-Hsp60 and especially anti-Hsp70 correlate with the attacks and severity of asthma. The underlying molecular mechanisms linking antibodies to heat shock proteins and asthma remain to be investigated

A Participatory Approach to Assessing the Climate-Smartness of Agricultural Interventions: The Lushoto Case

The concept of climate-smart agriculture (CSA) is gaining momentum across the globe. However, it is not specific on what should be covered under its three pillars—productivity, resilience and mitigation. Consequently, CSA encompasses many different agricultural practices/technologies, making it difficult to prioritise CSA objectives. Firstly, there is a lack of clear and workable criteria as well as methods for assessing the climate-smartness of interventions. Secondly, little information exists about the impact of the various interventions already promoted as CSA, especially in the developing world. Finally, CSA prioritisation does not take into account stakeholders’ perspectives to ensure that the interventions are applicable, suitable and of high adoption-potential. Here, we describe a new participatory protocol for assessing the climate-smartness of agricultural interventions in smallholder practices. This identifies farm-level indicators (and indices) for the food security and adaptation pillars of CSA. It also supports the participatory scoring of indicators, enabling baseline and future assessments of climate-smartness to be made. The protocol was tested among 72 farmers implementing a variety of CSA interventions in the climate-smart village of Lushoto, Tanzania. Farmers especially valued interventions that improved soil fertility and structure, reduced surface runoff, and reclaimed degraded land due to the positive impacts on yield and off-season crop agriculture. Mostly, the CSA interventions increased animal production, food production, consumption and income. The protocol is easy to adapt to different regions and farming systems and allows for the better prioritisation of interventions. But we recommend that CSA is adopted as part of a monitoring, evaluation and learning process

Palaeoecological data indicates land-use changes across Europe linked tospatial heterogeneity in mortality during the Black Death pandemic

Historical accounts of the mortality outcomes of the Black Death plague pandemic are variable across Europe, with much higher death tolls suggested in some areas than others. Here the authors use a `big data palaeoecology&apos; approach to show that land use change following the pandemic was spatially variable across Europe, confirming heterogeneous responses with empirical data. The Black Death (1347-1352 ce) is the most renowned pandemic in human history, believed by many to have killed half of Europe&apos;s population. However, despite advances in ancient DNA research that conclusively identified the pandemic&apos;s causative agent (bacterium Yersinia pestis), our knowledge of the Black Death remains limited, based primarily on qualitative remarks in medieval written sources available for some areas of Western Europe. Here, we remedy this situation by applying a pioneering new approach, `big data palaeoecology&apos;, which, starting from palynological data, evaluates the scale of the Black Death&apos;s mortality on a regional scale across Europe. We collected pollen data on landscape change from 261 radiocarbon-dated coring sites (lakes and wetlands) located across 19 modern-day European countries. We used two independent methods of analysis to evaluate whether the changes we see in the landscape at the time of the Black Death agree with the hypothesis that a large portion of the population, upwards of half, died within a few years in the 21 historical regions we studied. While we can confirm that the Black Death had a devastating impact in some regions, we found that it had negligible or no impact in others. These inter-regional differences in the Black Death&apos;s mortality across Europe demonstrate the significance of cultural, ecological, economic, societal and climatic factors that mediated the dissemination and impact of the disease. The complex interplay of these factors, along with the historical ecology of plague, should be a focus of future research on historical pandemics

Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study

Background Given the morbidity and mortality of asthma and the recent dramatic increase in its prevalence, pharmacologic prophylaxis of this disease in children at risk would represent a major medical advance.Objectives The Preventia I Study was designed to evaluate the efficacy and long-term safety of loratadine in reducing the number of respiratory infections in children at 24 months. A secondary objective was to investigate the benefit of loratadine treatment in preventing the onset of respiratory exacerbations.Methods Preventia I was a randomized placebo-controlled study involving 22 countries worldwide. The children were 12–30 months of age at enrolment and had experienced at least five episodes of ENT infections, and no more than two episodes of wheezing during the previous 12 months. Phase I was a 12-month double-blind period during which the children were treated with loratadine 5 mg/day (2.5 mg/day for children24 months of age) or placebo. Phase II was a double-blind follow-up period without study medication.Results Of the 412 children enrolled, 342 and 310 completed Phase I and Phase II, respectively. The results showed a significant decrease in the number of infections in the whole population of children. However, no difference was observed between the loratadine and placebo group. When considering secondary end-points, loratadine was shown to reduce the number of respiratory exacerbations during the treatment phase. None of the 204 children who received loratadine discontinued the study because of drug-related events. Loratadine treatment was not more sedative than placebo and was not associated with cardiovascular events.Conclusion The strong decrease in the rate of infections in the children at risk of recurrent infections, while not being influenced by loratadine treatment, should encourage future reflection in terms of prophylactic management. This study also confirms the long-term safety of loratadine and its metabolites in young children